MLXIPL and metabolic dysfunction-associated steatotic liver disease: In summary, our study established a functional role of FTO during the fasting–feeding cycle and in the pathogenesis of NAFLD, which responded to insulin and promoted hepatic lipogenesis by stabilizing SREBF1 and ChREBP mRNAs.